Significant correlation of hypoxia-inducible factor-1α with treatment outcome in cervical cancer treated with radical radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 2, 2003, Pages 494-501

  Burri, Philipp ^a   Djonov, Valentin ^b   Aebersold, Daniel M ^a   Lindel, Katja ^a   Studer, Ueli ^a   Altermatt, Hans J ^a   Mazzucchelli, Luca ^c   Greiner, Richard H ^a   Gruber, Günther ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Pathology Laenggasse   (Switzerland)

Author keywords

Cervical cancer; Hemoglobin; Hypoxia inducible factor 1 ; Radiotherapy

Indexed keywords

CORRELATION METHODS; HEMOGLOBIN; RADIOTHERAPY; TUMORS;

CERVICAL CANCER;

ONCOLOGY;

HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR BIOPSY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA;

EID: 0038300418     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04579-0     Document Type: Article

References (48)

1. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Dev Biol. 15:1999;551-578.
2. 2 tension. Proc Natl Acad Sci USA. 92:1995;5510-5514.
3. Jewell U.R., Kvietikova I., Scheid A., et al. Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J. 15:2001;1312-1314.
4. Vukovic V., Haugland H.K., Nicklee T., et al. Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res. 61:2001;7394-7398.
5. Nordsmark M., Overgaard M., Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 41:1996;31-39.
6. Gatenby R.A., Kessler H.B., Rosenblum J.S., et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 14:1988;831-838.
7. Hockel M., Vorndran B., Schlenger K., et al. Tumor oxygenation A new predictive parameter in locally advanced cancer of the uterine cervix . Gynecol Oncol. 51:1993;141-149.
8. Fyles A.W., Milosevic M., Wong R., et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol. 48:1998;149-156.
9. Rofstad E.K., Sundfor K., Lyng H., et al. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer. 83:2000;354-359.
10. Stone H.B., Brown J.M., Phillips T.L., et al. Oxygen in human tumors correlations between methods of measurement and response to therapy: Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland . Radiat Res. 136:1993;422-434.
11. Raleigh J.A., Dewhirst M.W., Thrall D.E. Measuring tumor hypoxia. Semin Radiat Oncol. 6:1996;37-45.
12. Aebersold D.M., Burri P., Beer K.T., et al. Expression of hypoxia-inducible factor-1alpha A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer . Cancer Res. 61:2001;2911-2916.
13. Birner P., Schindl M., Obermair A., et al. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 60:2000;4693-4696.
14. Ryan H.E., Lo J., Johnson R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17:1998;3005-3015.
15. Barillot I., Horiot J.C., Pigneux J., et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone A French cooperative study - Update and multivariate analysis of prognostics factors . Int J Radiat Oncol Biol Phys. 38:1997;969-978.
16. Logsdon M.D., Eifel P.J. FIGO IIIB squamous cell carcinoma of the cervix An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy . Int J Radiat Oncol Biol Phys. 43:1999;763-775.
17. Lanciano R.M., Won M., Coia L.R., et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix A final report of the 1973 and 1978 patterns of care studies . Int J Radiat Oncol Biol Phys. 20:1991;667-676.
18. Pedersen D., Sogaard H., Overgaard J., et al. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone. Acta Oncol. 34:1995;787-795.
19. Zhong H., De Marzo A.M., Laughner E., et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59:1999;5830-5835.
20. Maxwell P.H., Wiesener M.S., Chang G.W., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:1999;271-275.
21. Jiang B.H., Agani F., Passaniti A., et al. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1 Involvement of HIF-1 in tumor progression . Cancer Res. 57:1997;5328-5335.
22. Feldser D., Agani F., Iyer N.V., et al. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 59:1999;3915-3918.
23. Zhong H., Chiles K., Feldser D., et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells Implications for tumor angiogenesis and therapeutics . Cancer Res. 60:2000;1541-1545.
24. 2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol. 53:1999;99-104.
25. Hockel M., Schlenger K., Aral B., et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
26. Haensgen G., Krause U., Becker A., et al. Tumor hypoxia, p53, and prognosis in cervical cancers. Int J Radiat Oncol Biol Phys. 50:2001;865-872.
27. Hall E.J. The oxygen effect and reoxygenation. Hall E.J. Radiobiology for the radiologist. 4th ed:1994;133-136 JB Lippincott, Philadelphia.
28. Reynolds T.Y., Rockwell S., Glazer P.M. Genetic instability induced by the tumor microenvironment. Cancer Res. 56:1996;5754-5757.
29. Rofstad E.K. Microenvironment-induced cancer metastasis. Int J Radiat Biol. 76:2000;589-605.
30. Graeber T.G., Osmanian C., Jacks T., et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 379:1996;88-91.
31. An W.G., Kanekal M., Simon M.C., et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature. 392:1998;405-408.
32. Carmeliet P., Dor Y., Herbert J.M., et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:1998;485-490.
33. Vaupel P., Kelleher D.K. Tumor hypoxia. 1999;Wissenschaftliche Verlagsgesellschaft, Stuttgart.
34. Vaupel P., Thews O., Hoeckel M. Treatment resistance of solid tumors Role of hypoxia and anemia . Med Oncol. 18:2001;243-259.
35. Kapp K.S., Stuecklschweiger G.F., Kapp D.S., et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 42:1998;531-540.
36. Thomas G. The effect of hemoglobin level on radiotherapy outcomes The Canadian experience . Semin Oncol. 28:(2 Suppl. 8):2001;60-65.
37. Bush R.S. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys. 12:1986;2047-2050.
38. Dische S. Radiotherapy and anaemia - The clinical experience. Radiother Oncol. 1:1991;35-40.
39. Hill R., Bush R., Yeung P. The effect of anemia on the fraction of hypoxic cells in an experimental tumor. Br J Radiol. 44:1971;299-304.
40. Kelleher D.K., Mattheinsen U., Thews O., et al. Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats. Cancer Res. 56:1996;4728-4734.
41. Becker A., Stadler P., Lavey R.S., et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 46:2000;459-466.
42. Vaupel P., Höckel M. Oxygenation of human tumors. Molls M., Vaupel P. Blood perfusion and microenvironment of human tumors. 2000;63-72 Springer, Berlin.
43. Molls M., Stadler P., Becker A., et al. Relevance of oxygen in radiation oncology Mechanisms of action, correlation to low hemoglobin levels . Strahlenther Onkol. 4:1998;13-16.
44. Konerding M.A., Malkusch W., Klapthor B., et al. Evidence for characteristic vascular patterns in solid tumours Quantitative studies using corrosion casts . Br J Cancer. 80:1999;724-732.
45. Denekamp J. Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev. 9:1990;267-282.
46. Molls M., Vaupel P. Blood perfusion and microenvironment of human tumors. 2000;Springer, Berlin.
47. Wouters B.G., Weppler S.A., Koritzinsky M., et al. Hypoxia as a target for combined modality treatments. Eur J Cancer. 38:2002;240-257.
48. Fyles A., Milosevic M., Hedley D., et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol. 20:2002;680-687.